Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes

Blood

Volumn 92, Issue 11, 1998, Pages 4220-4229

  Chandra, Joya ^a,b   Niemer, Irina ^a,b   Gilbreath, Joyce ^a,b   Kliche, Kay Oliver ^a,b   Andreeff, Michael ^a,b   Freireich, Emil J ^a,b   Keating, Michael ^a,b   McConkey, David J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; PROTEASOME INHIBITOR; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DNA DEGRADATION; DNA DETERMINATION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL;

EID: 0032402111     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.11.4220     Document Type: Article

References (48)

1. Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelman WN, Plunkett W: Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-β-D-arabinosyl-2'fluoroadenine. Blood 81:143, 1993
2. Consoli U, El-Tounsi I, Sandoval A, Snell V, Kleine HD, Brown W, Robinson JR, DiRaimondo F, Plunkett W, Andreeff M: Differential induction of apoptosis by fludarabine monophoshate in leukemic B and normal T cells in chronic lymphocytic leukemia. Blood 91:1742, 1998
3. Huang P, Robertson LE, Wright S, Plunkett W: High molecular weight DNA fragmentation: A critical event in nucleoside analogue-induced apoptosis in leukemia cells. Clin Cancer Res 1:1005, 1995
4. Henkart PA: ICE family proteases: Mediators of all apoptotic cell death? Immunity 4:195, 1996
5. Martin SJ, Green DR: Protease activation during apoptosis: Death by a thousand cuts? Cell 82:349, 1995
6. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz. R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel FADD-homologous ICE/CED3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817, 1996
7. Liu X, Kim CN, Yang J, Jemmerson R, Wang X: Induction of the apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c.Cell 86:147, 1996
8. Cohen GM: Caspases: The executioners of apoptosis. Biochem J 326:1, 1997
9. Chandra J, Gilbreath J, Freireich EJ, Kliche KO, Andreeff M, Keating M, McConkey DJ: Protease activation is required for glucocor-ticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes. Blood 90:3673, 1997
10. Clawson GA, Norbeck LL, Hatem CL, Rhodes C, Amiri P, McKerrow JH, Patierno SR, Fiskum G: Ca2 + -regulated serine protease associated with the nuclear scaffold. Cell Growth Differ 3:827, 1992
11. Schwartz LM, Smith SW, Jones MEE, Osborne BA: Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci USA 90:980, 1993
12. Grimm LM, Goldberg AL, Poirier GG, Schwartz LM, Osborne BA: Proteasomes play an essential role in thymocyte apoptosis. EMBO J 15:3835, 1996
13. Sadoul R, Fernandez PA, Quiquerez AL, Martinou I, Muki M, Schroter M, Becherer JD, Irmler M, Tschopp J, Martinou JC: Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J 15:3845, 1996
14. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D: Embryonic lethality and liver degeneration in mice lacking the RelA component of NFκB. Nature 376:167, 1995
15. Beg AA, Baltimore D: An essential role for NFκB in preventing TNFα-induced cell death. Nature 274:782, 1996
16. Wang CY, Mayo MW, Baldwin AS: TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NFκB. Nature 274:784, 1996
17. Antwerp DJV, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNFa-induced apoptosis by NFκB. Nature 274:787, 1996
18. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS: Clinical staging of chronic lymphocytic leukemia. Blood 46:219, 1975
19. Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK: Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 22:1003, 1994
20. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidiurn iodide staining and flow cytometry. J Immunol Methods 139:271, 1991.
21. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wagg X: Prevention of apoptosis by bcl-2: Release of cytochromec from mitochondria blocked. Science 275:1129, 1997
22. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keelman RMJ, Pals ST, Oers MHJv: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415, 1994
23. McConkey DJ, Chandra J, Wright S, Plunkett W, McDonnell TJ, Reed JC, Keating MJ: Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J Immunol 156:2624, 1996
24. Bellosillo BDM, Colomer D, Gil J: Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells. Blood 89:3378, 1997
25. Krajewski S GR, Zapata JM, Krajewska M, Kitada S, Chhanabhai M, Horsman D, Berean K, Piro LD, Fugier-Vivier I, Liu YJ, Wang HG, Reed JC: Immunolocalization of the ICE/Ced-3-family protease, CPP-32 (Caspuse-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes. Blood 89:3817, 1997
26. Li P, Nijhawan D, Budihurdjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-l/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479, 1997
27. Kroemer G, Zamzami N, Susin SA: Mitochondrial control of apoptosis. Immunol Today 18:44, 1997
28. Lopes UG, Erhardt P, Yao R, Cooper GM: p53-dependent induction of apoptosis by proteasome inhibitors. J Biol Chem 272: 12893, 1997
29. Stancovski I, Gonen H, Orian A, Schwartz AL, Ciechanover A: Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: Identification and characterization of the conjugating enzymes. Mol Cell Biol 15:7106, 1995
30. Jariel-Encontre I, Pariat M, Martin F, Carillo S, Salvat C, Piechaczyk M: Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome. J Biol Chem 270:11623, 1995
31. Bonvini P, Nguyen P, Trepel J, Neckers LM: In vivo degradation of N-myc in neuroblastoma cells is mediated by the 26S proteasome. Oncogene 16:1131, 1998
32. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Sal GD, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682, 1995
33. Traenckner EBM, Wilk S, Baeuerle PA: A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IkB-α that is still bound to NF-κB. EMBOJ 13:5433, 1994
34. Verma IM, Stevenson JK, Schwartz EM, Antwerp DV, Miyamoto S: Rel/NFκB/IκB family: Intimate tales of association and dissociation. Genes Dev 9:2723, 1996
35. Delic J, Masdehors P, Omura S, Cosset JM, Dumont J, Binet JL, Magdelenat H: The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemic lymphocytes to TNF alpha-initiated apoptosis. Br J Cancer 77:1103, 1998
36. Ghislain M, Udvardy A, Mann C: S. cerevisiae 26S protease mutants arrest cell division in G2/metaphase. Nature 366:358, 1993
37. Glas R, Bogyo M, McMaster JS, Gaczynska M, Ploegh HL: A proteolytic system that compensates for loss of proteasome function. Nature 392:618, 1998
38. Baeuerle PA, Baltimore D: NF-κB: Ten Years After. Cell 87:13, 1996
39. Hochstrasser M: Ubiquitin, proteasomes, and the regulation of intracellar protein degradation. Curr Opin Cell Biol 7:215, 1995
40. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, FitzGerald MJ, Rothstein TL, Sherr DH, Sonenshein GE: Inhibition of NFκB/Rel induces apoptosis of murine B cells, EMBO J 15:4682, 1995
41. Ray A, Prefontaine KE: Physical association and functional antagonism between the p65 subunit of transcription factor NFκB and the glucocorticoid receptor. Proc Natl Acad Sci USA 91:752, 1994
42. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS: Characterization of mechanisms involved in transrepression of NFκB by activated glucocorticoid receptors. Mol Cell Biol 15:943, 1995
43. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS: Role of transcription activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283, 1995
44. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M: Immunosuppression by glucocorticoids: Inhibition of NFκB activity through induction of IκBa synthesis. Science 270:286, 1995
45. Drexler HCA: Activation of the cell death program by inhibition of proteasome function. Proc Natl Acad Sci USA 94:855, 1997
46. Soldatenkov VA, Dritschilo A: Apoptosis of Ewing's sarcoma cells is accompanied by accumulation of ubiquinated proteins. Cancer Res 57:3881, 1997
47. Delic J, Morange M, Magdelenat H: Ubiquitin pathway involvement in human lymphocyte γ-irradiation-induced apoptosis. Mol Cell Biol 13:4875, 1993
48. Drexler HCA: Programmed cell death and the proteasome. Apoptosis 3:1, 1998